Font Size: a A A

Obese Type 2 Diabetes Clinical Observation Bo's Abdominal Acupuncture

Posted on:2015-02-24Degree:MasterType:Thesis
Country:ChinaCandidate:Y YangFull Text:PDF
GTID:2264330428474706Subject:Acupuncture and Massage
Abstract/Summary:PDF Full Text Request
Objective:To observe the difference in the effectiveness of obese type2diabetes (T2DM) through Bo’s abdominal acupuncture and medicine,objectively evaluate Bo’s abdominal acupuncture’s clinical efficacy and application value in the treatment of obese type2diabetes. To summarize Bo’s abdominal acupuncture’s function characteristic in the treatment of obese type2diabetes, make a safe, effective and practical method for the clinical treatment of obese type2diabetes.Methods:60patients met the inclusion criteria as the research objects, who were divided into Bo’s abdominal acupuncture treatment group and the control group,30cases in each group,according to a randomized,controlled clinical trial methodology. The control group used base therapy(diet therapy, exercise therapy) with conventional oral hypoglycemic drugs,minus3weeks for a course of treatment. Bo’s abdominal acupuncture treatment group was on the basis of the control group therapy and used Bo’s abdominal acupuncture. Acupoints:Yin Qi Gui Yuan(Zhong Wan,Xia Wan,Qi Hai,Guan Yuan),Fu Si Guan(Hu a Rou Men,Wai Ling),Tian Shu,Da Heng,Qi Xue,Shang Feng Shi Dian,Tai Yi,Shui Dao. Therapy3times a week,3weeks a course of treatment. At the beginning and end of treatment,recorded blood pressure,height,weight,WC,hip and calcu lated WHR,BMI according to the formula and tested FPG,OGTT2hPG,FINS,OGTT2h insulin,TC,TG,LDL,HDL and calculated IAI,HOMA-IR according to the formula. Recorded TCM syndrome score.After treatment,according to the"standard of diagnosis of TCM curative effect"determined efficacy. Using SPSS17.0statist ical software, measurement data using x±S,comparison between the normal distribution measurement data set using T test,non-normal distribution data using Wilcoxon test,counting data to rate(%),comparison between groups usi ng Wilcoxon test,P<0.05for the difference was statistically significant.Results:(1)In the Bo’s abdominal acupuncture group,patients’SBP,WC,weig ht,BMI,FPG,OGTT2hBG,FINS,OGTT2h insulin,IAI,HOMA-IR,TC,LDL-C,TCM syndrome score significantly reduced, there was significant difference (P<0.05). DBP, WHR.TG also decreased,but the difference was not statistically significant. HDL-C increased,but the difference was not statistically significant.(2)In the control group, patients’FPG,OGTT2h insulin,TG increased than before,there was a significant difference(P<0.05). IAI lowered after treatme nt than before,there was a significant difference.Patients’SBP.WC,weight,BMI,OGTT2hBG,FINS,TC,HDL-C slightly lowered,the differences were not statistically significant. WHR didn’t significantly change. DBP,HOMA-IR,LDL-C, the TCM symptom score increased,but the differences were not statistically significant.(3)The comparations between two groups:Bo’s abdominal acupuncture group’ s total effective rate was93.33%. In the control group,the total effective rate was23.33%. The difference was significant (P<0.01).The total efficienc y of Bo’s abdominal acupuncture in the treatment of obese type2diabetes was significantly better than the control group.The differences of two groups in reducing SBP,WC,FPG,OGTT2h insulin,HOM A-IR,TC,TG,LDL-C,TCM syndrome score were significant(P<0.05). In DBP,weight, BMI,WHR,OGTT2hBG,FINS,IAI,HDL-C,there were no significant differences betwe en the treatment group and the control group.Conclusion:Bo’s abdominal acupuncture in the treatment of obese type2diabetes has obviously clinical efficacy. The effect of controlling blood pressure, lossing weight,lowering blood glucose,reducing insulin resistance, lowering lipid is prominent. Especially the rolls for reducing SBP,WC,FPG,0GTT2h insulin,HOMA-IR,TC,TG,LDL-C,TCM syndrome are worthy of recognition. Bo ’s abdominal acupuncture has no side effects and is worthy of clinical appl ication.
Keywords/Search Tags:Bo’s abdominal acupuncture, obese type2diabetes, efficacy observation
PDF Full Text Request
Related items